National Bank Financial Issues Positive Forecast for Kinaxis (TSE:KXS) Stock Price

Kinaxis (TSE:KXS – Get Free Report) had its price target boosted by equities researchers at National Bank Financial from C$210.00 to C$245.00 in a report issued on Monday, BayStreet reports. The firm presently has an “outperform” rating on the stock. National Bank Financial‘s price objective suggests a potential upside of 17.53% from the company’s current price.

A number of other analysts have also weighed in on KXS. Stifel Nicolaus upped their price objective on Kinaxis from C$200.00 to C$225.00 and gave the stock a “buy” rating in a research report on Thursday, October 29th. BMO Capital Markets lifted their target price on Kinaxis from C$195.00 to C$200.00 and gave the company an “outperform” rating in a report on Friday, August 7th. Royal Bank Of Canada set a C$210.00 price target on shares of Kinaxis and gave the stock an “outperform” rating in a report on Wednesday, August 26th. Finally, RBC Dominion Securities set a C$210.00 price objective on Kinaxis and gave the stock an “outperform” rating in a research report on Friday, October 23rd. Eight equities research analysts have rated the stock with a Buy rating. According to data from MarketBeat.com, the company currently has a consensus rating of “Buy” and a consensus target price of C$210.56.

Check Out Our Latest Stock Report on Kinaxis

Kinaxis Stock Up 0.9%

Shares of TSE KXS traded up C$1.77 during midday trading on Monday, hitting C$208.46. The company’s stock had a trading volume of 44,608 shares, compared to its average volume of 126,235. The company has a debt-to-equity ratio of 11.18, a current ratio of 1.81 and a quick ratio of 2.29. The firm has a market capitalization of C$5.64 billion, a price-to-earnings ratio of 65.14, a price-to-earnings-growth ratio of 3.60 and a beta of 0.43. The business’s fifty day simple moving average is C$182.77 and its two-hundred day simple moving average is C$156.56. Kinaxis has a 1 year low of C$117.22 and a 1 year high of C$209.12.

Kinaxis (TSE:KXS – Get Free Report) last announced its earnings results on Wednesday, November 4th. The company reported C$1.72 earnings per share for the quarter. Kinaxis had a net margin of 14.33% and a return on equity of 22.26%. The firm had revenue of C$228.16 million for the quarter. On average, equities analysts predict that Kinaxis will post 4.25 EPS for the current year.

Insider Transactions at Kinaxis

In related news, Director Gillian H. (Jill) Denham sold 15,968 shares of the company’s stock in a transaction on Tuesday, August 11th. The stock was sold at an average price of C$171.36, for a total transaction of C$2,736,276.48. Following the transaction, the director owned 18,732 shares of the company’s stock, valued at C$3,209,915.52. This represents a 46.02% decrease in their ownership of the stock. Also, insider Mark Justin Morgan sold 3,000 shares of the stock in a transaction on Tuesday, August 11th. The stock was sold at an average price of C$172.25, for a total value of C$516,750.00. Following the completion of the transaction, the insider owned 10,299 shares of the company’s stock, valued at C$1,774,002.75. The trade was a 22.56% decrease in their position. Insiders sold a total of 33,730 shares of company stock worth $5,877,368 over the last quarter. 1.20% of the stock is currently owned by corporate insiders.

About Kinaxis

(Get Free Report)

Kinaxis is a leader in modern supply chain orchestration, powering complex global supply chains, and supporting the people who manage them. Our powerful, AI-infused supply chain orchestration platform, Maestro, combines proprietary technologies and techniques that provide full transparency and agility across the entire supply chain – from multi-year strategic planning to last-mile delivery. We are trusted by renowned global brands to provide the agility and predictability needed to navigate today’s volatility and disruption.

Featured Stories

Analyst Recommendations for Kinaxis (TSE:KXS)

Receive News & Ratings for Kinaxis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kinaxis and related companies with MarketBeat.com's FREE daily email newsletter.